Darling Ingredients (NYSE: DAR) insider transactions
In the twelve months to 10 November 2026, executives and directors of Darling Ingredients reported 19 open-market sales of 92,546 shares ($5.3m) and 2 open-market purchases of 1,000 shares ($60,970), by 7 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 2 September 2026 | Stuewe Randall C | Chairman and CEO | Open-market sale | −5,000 | $68.20 | 1,133,467 | Form 4 |
| 18 August 2026 | Manzi Joseph | Chief Accounting Officer | Open-market sale | −1,000 | $67.27 | 18,969 | Form 4 |
| 17 August 2026 | Dudley Sandra | EVP Chief Strategy Officer | Option exercise | +5,928 | $18.82 | 84,036 | Form 4 |
| 17 August 2026 | Dudley Sandra | EVP Chief Strategy Officer | Shares withheld for tax | −3,330 | $67.88 | 80,706 | Form 4 |
| 17 August 2026 | Dudley Sandra | EVP Chief Strategy Officer | Open-market sale | −2,598 | $67.88 | 78,108 | Form 4 |
| 17 August 2026 | Dudley Sandra | EVP Chief Strategy Officer | Open-market sale | −3,876 | $67.87 | 74,232 | Form 4 |
| 14 August 2026 | McNutt Patrick | EVP Chief Admin Officer | Open-market sale | −8,000 | $67.09 | 35,777 | Form 4 |
| 13 August 2026 | Stuewe Randall C | Chairman and CEO | Open-market sale | −5,000 | $64.79 | 1,138,467 | Form 4 |
| 12 August 2026 | Stuewe Randall C | Chairman and CEO | Open-market sale | −5,000 | $63.26 | 1,143,467 | Form 4 |
| 10 August 2026 | Kemphaus Nicholas James | EVP Gen. Counsel & Secretary | Open-market sale | −1,591 | $63.05 | 35,087 | Form 4 |
| 31 July 2026 | Adair Charles L | Director | Open-market purchase | +500 | $60.67 | 51,190 | Form 4 |
| 31 July 2026 | Adair Charles L | Director | Open-market purchase | +500 | $61.27 | 51,690 | Form 4 |
| 7 May 2026 | Adair Charles L | Director | Grant or award | +2,650 | — | 50,690 | Form 4 |
| 7 May 2026 | Aspell Robert Patrick | Director | Grant or award | +2,650 | — | 3,199 | Form 4 |
| 7 May 2026 | Barden Larry | Director | Grant or award | +2,650 | — | 34,847 | Form 4 |
| 7 May 2026 | Barden Larry | Director | Grant or award | +261 | $37.64 | 35,108 | Form 4 |
| 7 May 2026 | Clark Celeste A. | Director | Grant or award | +2,650 | — | 20,437 | Form 4 |
| 7 May 2026 | Clark Celeste A. | Director | Grant or award | +130 | $37.64 | 20,567 | Form 4 |
| 7 May 2026 | Goodspeed Linda | Director | Grant or award | +2,650 | — | 42,836 | Form 4 |
| 7 May 2026 | Guimaraes Enderson | Director | Grant or award | +2,650 | — | 21,095 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Darling Ingredients page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.